α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical, and oncologic factors to the presence of elevated AFP levels in large cohort of patients with HCC.
Rapaccini, G. L., Gasbarrini, A., Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use, <<CANCER>>, 2014; 120 (14): 2150-2157. [doi:10.1002/cncr.28706] [http://hdl.handle.net/10807/60759]
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use
Rapaccini, Gian Ludovico;Gasbarrini, Antonio
2014
Abstract
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical, and oncologic factors to the presence of elevated AFP levels in large cohort of patients with HCC.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
